OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials
Paulo Ricardo Martins‐Filho, Edmundo Marques do Nascimento-Júnior, José Antônio Barreto-Alves, et al.
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 11, pp. 1813-1821
Open Access | Times Cited: 7
Paulo Ricardo Martins‐Filho, Edmundo Marques do Nascimento-Júnior, José Antônio Barreto-Alves, et al.
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 11, pp. 1813-1821
Open Access | Times Cited: 7
Showing 7 citing articles:
The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis
Shivani Singh, Simon Boyd, William HK Schilling, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 5, pp. 935-945
Open Access | Times Cited: 10
Shivani Singh, Simon Boyd, William HK Schilling, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 5, pp. 935-945
Open Access | Times Cited: 10
DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR THE QUANTITATIVE DETERMINATION OF NITAZOXANIDE AND IT’S RELATED SUBSTANCES IN ACTIVE PHARMACEUTICAL INGREDIENTS
Tata Santosh, Prafulla Kumar Sahu
Asian Journal of Pharmaceutical and Clinical Research (2025), pp. 146-152
Open Access
Tata Santosh, Prafulla Kumar Sahu
Asian Journal of Pharmaceutical and Clinical Research (2025), pp. 146-152
Open Access
The African Kelleni’s roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one
Mina Kelleni
Inflammopharmacology (2023) Vol. 31, Iss. 6, pp. 3335-3338
Open Access | Times Cited: 9
Mina Kelleni
Inflammopharmacology (2023) Vol. 31, Iss. 6, pp. 3335-3338
Open Access | Times Cited: 9
Systems medicine framework for repurposable drug combinations for COVID-19 comorbidities
S. Saranya, L. Thamanna, P. Chellapandi
Medicine in Omics (2024) Vol. 11, pp. 100038-100038
Open Access | Times Cited: 1
S. Saranya, L. Thamanna, P. Chellapandi
Medicine in Omics (2024) Vol. 11, pp. 100038-100038
Open Access | Times Cited: 1
Nitazoxanide in the Treatment of COVID-19: A paradigm for Antiviral Drugs Targeting Host-Infected Cells
Christian Bréchot, Jean François Rossignol
Medical Research Archives (2024) Vol. 12, Iss. 4
Open Access
Christian Bréchot, Jean François Rossignol
Medical Research Archives (2024) Vol. 12, Iss. 4
Open Access
Clinical Experience With Ivermectin and Nitazoxanide in the Management of COVID-19 Among Mexican Out- and Inpatients
Jorge García-Méndez, Luis E. Fernández-Garza, Karen Vallejo-Oviedo, et al.
Cureus (2024)
Open Access
Jorge García-Méndez, Luis E. Fernández-Garza, Karen Vallejo-Oviedo, et al.
Cureus (2024)
Open Access
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Tzu-Chieh Weng, Teng-Song Weng, Chih‐Cheng Lai, et al.
Expert Review of Anti-infective Therapy (2022) Vol. 20, Iss. 12, pp. 1615-1622
Closed Access | Times Cited: 2
Tzu-Chieh Weng, Teng-Song Weng, Chih‐Cheng Lai, et al.
Expert Review of Anti-infective Therapy (2022) Vol. 20, Iss. 12, pp. 1615-1622
Closed Access | Times Cited: 2
